Inhaled nitric oxide (iNO) therapy is used in neonatal care as a selective pulmonary vasodilator to improve oxygenation and reduce pulmonary vascular resistance. In preterm infants, the application of ...
GARDEN CITY, N.Y., Sept. 27, 2024 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the ...
GARDEN CITY, N.Y., July 31, 2024 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on ...
Researchers have posted the results of a multisystem phase II clinical trial of patients with COVID-19 and respiratory failure Patients who received inhaled nitric oxide had improved blood oxygen ...
Acute respiratory distress syndrome, or ARDS, is a condition that most commonly occurs in the setting of a lung infection such as COVID-19. “In ARDS, the barrier between the blood vessels and air sacs ...
NEW YORK (Reuters Health) - Infants born prematurely at very low birth weights who are treated with inhaled nitric oxide in the neonatal intensive care unit are significantly less likely to need ...